DataHow AG

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Profile

DataHow AG is a spin-off company from ETH Zurich specialized in data analytics and process modeling for the process industry with a particular focus on the production of biopharmaceuticals.

We offer digital solutions and consulting for process screening, monitoring, optimization, control and scale-up. Our goal is to reduce the effort, risks and costs in process development and manufacturing as well as to gain deep understanding of the complex processes.

DataHow emerged in 2017 from the research group of Prof. Morbidelli at ETH Zurich based on the activities of Dr. Alessandro Butté, Michael Sokolov and Fabian Feidl.

Year Founded
2017
Alessandro Butté
Lecturer and Senior Researcher 
Conference attendance
Fabian Feidl
Co-founder, PhD Candidate ETH 
Conference attendance
Michael Sokolov
Co-founder, COO, Postdoc ETH 
Conference attendance

Di Meliora

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Volker Hogg
CEO 
Conference attendance

Dicronis

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Website
www.dicronis.com
Company Profile
At Dicronis, we are developing the first DIY lymphatic activity tracker, featuring a microneedles-covered patch and a wearable detector. The microneedles-mediated skin delivery of a fluorescent agent and the measure of its disappearance rate with a coupled wearable device allows for assessment of the dermal lymphatic function. Being minimally-invasive, painless and simple empower it to be used in a home setting by the patient, and accordingly, allow for a much better monitoring on the lymphatic health. This is highly relevant for basic or nutritional research purposes, to evaluate novel therapeutics or as diagnostic biomarker in diseases where this is disrupted, leading to debilitating consequences. For instance, lymphedema, a condition frequently occurring after cancer treatments, outlined by the swelling of a limb. Early diagnosis of the disease is highly crucial to ensure conservative measures, e.g. lymphatic draining massages or compression garments, are employed early-on for best management of the disease. Indeed, current methods of diagnosis of lymphedema are driven, by the clinical manifestation of the symptoms, which delay disease management and therefore worsen the prognosis.
Jovan Jancev
Head of R&D 
Conference attendance
Patrizia Marschalkova
Co-Founder & Project leader at Dicronis 
Conference attendance

Dolopharm Biosciences UG

Presentation Time and Location
on 27th, during Rising Biotech Stars Session (from 14.00 to 16.00)
Company Profile

Dolopharm is a drug development company from Charité, Berlin, with a focus on GPCR-targeted therapies. Our first pipeline candidate NFEPP for the treatment of severe acute and chronic pain has shown impressive performance in several pre-clinical trial models. In contrast to standard medications, such as opioids, NFEPP avoids drug addiction, respiratory depression, constipation and other known side effects thus representing a potential breakthrough medication for many pain related indications. 

Company Type
Keywords

Drug Development

New Drugs

Pain therapy

Year Founded
2017
Financial Summary

Start-up seeking for initial financing

Pipeline Product 1: Name/Stage
NFEPP/Preclinical
Investment and Licensing (In/Out) Opportunity 1: Name
NFEPP
Opportunity 1: Description

We are currently looking for investors to finance our clinical phase I studies in post-operative pain treatment after knee surgery. So, feel free to talk to us and find out, how to join this outstanding investment opportunity.

Alexander Herrmann
CEO 
Conference attendance

Drooms AG

Company Website
https://www.drooms.com/en
Company Profile

Drooms AG is a leading European provider of secure cloud solutions. This software specialist facilitates highly secure access to confidential documents as well as the ability to safely exchange them with third parties beyond company firewalls. Confidential business processes, such as financing and licensing projects or Board Communication are handled securely, transparently and efficiently with Drooms. Headquartered in Frankfurt, Germany´s banking hub, Drooms is also expanding its global market presence and now has offices  in Munich, London, Paris, Amsterdam, Zug, Madrid, Milan and Vienna. The company is well positioned  to facilitate large-scale local and multi-jurisdictional transactions. Their professional expertise, top-tier reputation and innovative processes have laid the groundwork for a  growing reputation in this market space. Selected References include Astellas, Hormosan, HRA Pharma, Novartis, NovImmune SA and Siemens.

Miriam Muendnich
Press officer DACH 
Conference attendance
Luisa Jacinto Fragata
Luisa Jacinto Fragata
Senior Business Development Manager 
Conference attendance